FLT3 and acute myeloid leukemia: This review provides an overview on the established and evolving potential use of FLT3 inhibitors to prevent or treat AML relapse in post-transplantation context and addresses pending questions regarding its immunogenicity and the mechanisms of leukemia relapse during or after treatment.